| Product Code: ETC8260246 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Mauritius witnessed a shift in the concentration of large molecule drug substance CDMO import shipments, moving from high to moderate concentration. The top exporting countries to Mauritius in 2024 were India, Metropolitan France, Germany, Turkey, and the UK, indicating a diverse source of imports. Despite a slight decrease in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) from 2020 to 2024 remained positive at 4.65%. This data suggests a stable and resilient market for large molecule drug substance imports in Mauritius, with potential for further growth and diversification in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Large Molecule Drug Substance CDMO Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Mauritius Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Mauritius Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Large Molecule Drug Substance CDMO Market Trends |
6 Mauritius Large Molecule Drug Substance CDMO Market, By Types |
6.1 Mauritius Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Mauritius Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mauritius Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Mauritius Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Mauritius Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Mauritius Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Mauritius Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Mauritius Large Molecule Drug Substance CDMO Market Key Performance Indicators |
9 Mauritius Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Mauritius Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Mauritius Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Mauritius Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Mauritius Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Mauritius Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |